What is Ceftriaxone Injection Used For?
Ceftriaxone injection is a broad-spectrum cephalosporin antibiotic used to treat a variety of bacterial infections. It is effective against numerous gram-positive and gram-negative bacteria [1]. The medication works by stopping the growth of bacteria [2].
What Specific Infections Does Ceftriaxone Treat?
Ceftriaxone injection is prescribed for infections affecting different parts of the body, including:
* Respiratory Tract Infections: Such as pneumonia [1].
* Urinary Tract Infections: Including complicated urinary tract infections [1].
* Skin and Soft Tissue Infections: Treating various skin infections [1].
* Bone and Joint Infections: Addressing infections in bones and joints [1].
* Bloodstream Infections: Such as bacteremia and sepsis [1].
* Meningitis: It is used for bacterial meningitis [1].
* Gonorrhea: Ceftriaxone is a primary treatment for gonorrhea, including uncomplicated cases and disseminated gonococcal infections [1][3].
* Surgical Prophylaxis: It can be used to prevent infections before certain surgeries [1].
* Typhoid Fever: In some cases, it is used to treat typhoid fever [1].
How Does Ceftriaxone Work?
Ceftriaxone functions as a bactericidal agent, meaning it kills bacteria. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disruption prevents the formation of a stable bacterial cell wall, leading to cell lysis and death [2].
How is Ceftriaxone Administered?
Ceftriaxone is administered intravenously (IV) or intramuscularly (IM) [4]. Dosing and duration of treatment depend on the type and severity of the infection, as well as the patient's age and kidney function [4].
Who Manufactures Ceftriaxone?
Ceftriaxone is available as a generic medication, meaning multiple pharmaceutical companies manufacture it. Some common manufacturers include Fresenius Kabi, Pfizer (as Rocephin, the original brand name), and Aurobindo Pharma [5].
When Does Ceftriaxone Patent Exclusivity End?
Ceftriaxone itself is a well-established antibiotic, and its primary patents have long expired. The original brand name, Rocephin, was introduced by Roche in the early 1980s. Generic versions have been available for many years [6]. While specific patent expiry dates for older drugs are complex and often involve multiple patent types, the core patents for ceftriaxone have expired, allowing for generic competition [6]. Information on patent status and expiry for specific formulations or combination products may be available through resources like DrugPatentWatch.com [7].
What Are the Potential Side Effects of Ceftriaxone?
Common side effects of ceftriaxone injection include pain and swelling at the injection site, diarrhea, nausea, vomiting, rash, and headache [2]. More serious side effects, though less common, can include severe allergic reactions, blood disorders, liver problems, and a rare but serious condition called C. difficile-associated diarrhea [2]. Patients should report any concerning symptoms to their healthcare provider.